Evaluation reports
EN
ACTION - Actions for oncogenesis understanding and target identification in oncology
Type: Research unit evaluation report
Evaluation campaign: 2014-2015 (group A)
- Published on: 01/06/2015
Institution(s) concerned:
Université de Bordeaux
, Institut national de la santé et de la recherche médicale - INSERM
Disciplinary research field: Life and Earth Sciences (SVE) ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology ; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics
Name of unit teams: Oncogenesis and Therapeutic Targeting of the Sarcoma Cell (ONCOSARC) ; Genetic Diversity and Resistance to Therapy: Mammary and Leukemic Oncogenesis (LMLO) ; Validation and Identification of New Targets in cancer and AGEing (VINTAGE)
Keywords: Biologie cellulaire ; biologie moléculaire ; génétique moléculaire ; pharmacologie clinique ; cancer ; thérapies ciblées ; vieillissement ; sarcomes ; cancer du sein ; lymphomes ; SVE2_1 ; SVE2_3 ; SVE2_2 ; SVE6